GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
Company profile
Ticker
GSK, GLAXF
Exchange
Website
CEO
Emma Walmsley
Employees
Incorporated
Location
Industry (SIC)
Former names
GLAXOSMITHKLINE PLC
SEC CIK
GSK stock data
Latest filings (excl ownership)
6-K
Us Fda Accepts New Indication Filing for Jemperli
24 Apr 24
6-K
Director/pdmr Shareholding
19 Apr 24
6-K
Director/pdmr Shareholding
17 Apr 24
6-K
Results from Long-term Data Relating to Shingrix
17 Apr 24
6-K
GSK Announces Additional EAGLE-1 Results
17 Apr 24
6-K
Amendment - Director/pdmr Shareholding
16 Apr 24
6-K
Fda Accepts GSK Meningitis Vaccine Candidate File
16 Apr 24
6-K
Director/pdmr Shareholding
15 Apr 24
6-K/A
Replacement - Total Voting Rights
4 Apr 24
6-K
Total Voting Rights
2 Apr 24
Latest ownership filings
SC 13D/A
Nkarta, Inc.
28 Mar 24
SC 13G/A
DODGE & COX
13 Feb 24
SC 13D/A
23andMe Holding Co.
9 Feb 24
SC 13G/A
CureVac N.V.
6 Feb 24
SC 13G/A
Wave Life Sciences Ltd.
6 Feb 24
4
Wave Life Sciences Ltd.
30 Jan 24
SC 13D/A
Haleon plc
19 Jan 24
SC 13D/A
Haleon plc
10 Oct 23
SC 13D/A
Haleon plc
11 Sep 23
SC 13D/A
BICYCLE THERAPEUTICS plc
20 Jul 23
Financial summary
Quarter (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
11.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 714 |
Opened positions | 96 |
Closed positions | 194 |
Increased positions | 211 |
Reduced positions | 275 |
13F shares | Current |
---|---|
Total value | 8.07 tn |
Total shares | 245.60 mm |
Total puts | 197.29 k |
Total calls | 1.65 mm |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
Dodge & Cox | 69.03 mm | $2.56 tn |
FMR | 19.37 mm | $717.71 bn |
Fisher Asset Management | 15.04 mm | $557.27 bn |
T. Rowe Price | 12.82 mm | $475.07 mm |
JTC Employer Solutions Trusteee | 12.34 mm | $459.44 bn |
Primecap Management | 12.09 mm | $448.03 bn |
MS Morgan Stanley | 8.55 mm | $316.94 bn |
STT State Street | 7.05 mm | $263.82 bn |
Arrowstreet Capital, Limited Partnership | 4.82 mm | $178.63 mm |
GS Goldman Sachs | 4.02 mm | $148.80 bn |
News
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
26 Apr 24
What's Going On With Pfizer Stock On Thursday?
25 Apr 24
CureVac Has Started The Phase 1 Part Of A Combined Phase 1/2 Study Of An Investigational Influenza A (H5N1) Pre-Pandemic Vaccine Candidate Developed In Collaboration With GSK, H5N1 Is An Avian Influenza Virus
24 Apr 24
As Part Of Wave Life Sciences' Ongoing Collaboration With GSK, GSK Has Selected Its First Two Oligonucleotide Programs, GSK Will Provide An Initiation Payment Of $12M
23 Apr 24
Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
19 Apr 24
Press releases
WuXi Biologics Reports Solid 2023 Annual Results
26 Mar 24
Thinking about trading options or stock in Advanced Micro Devices, Amazon.com, Intel, GSK, or Viking Therapeutics?
21 Mar 24
Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer
16 Mar 24
Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research
12 Mar 24
GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise
7 Mar 24